STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America

Rebecca A. Marsh, Noriko Satake, Jennifer Biroschak, Thedia Jacobs, Judith Johnson, Michael B. Jordan, Jack J. Bleesing, Alexandra H. Filipovich, Kejian Zhang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background. Mutations in STX11 are responsible for Familial Hemophagocytic Lymphohistiocytosis (FHLH) type 4, a rare primary immunodeficiency which has previously been observed only in patients of Kurdish, Turkish, and Lebanese ethnic background. Methods. We reviewed our experience with STX11 mutations among North American patients and studied the impact of patient mutations upon syntaxin 11 expression and NK cell function. Results. Between 2007 and 2008, 243 patients with HLH (lacking disease-causing mutations in PRF1 and UNC13D) were referred for STX11 mutational analysis. We observed 1 novel homozygous nonsense mutation, 73 G> T (E25X), occurring in Hispanic siblings, and 2 novel biallelic heterozygous missense mutations, 106G> C (E36Q) and 616G>A (E206K), occurring in 1 Caucasian patient. The N-terminal nonsense mutation resulted in absence of detectable syntaxin 11 and abrogation of in vitro NK cell degranulation and function, while the biallelic heterozygous missense mutations resulted in detectable mutated syntaxin 11 and preservation of in vitro NK cell degranulation and cytotoxicity. The two sibling patients with the nonsense mutations presented with HLH during infancy, whereas the patient with biallelic heterozygous missense mutations presented at 5 years of age. Conclusion. We conclude that mutations in STX11 are responsible for HLH in approximately 1% of North American patients and can cause variable defects in syntaxin 11 expression and function with resultant impact on clinical phenotype.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalPediatric Blood and Cancer
Volume55
Issue number1
DOIs
StatePublished - Jul 15 2010

Fingerprint

Hemophagocytic Lymphohistiocytosis
North America
Qa-SNARE Proteins
Phenotype
Mutation
Nonsense Codon
Missense Mutation
Natural Killer Cells
Cell Degranulation
Siblings
Hispanic Americans

Keywords

  • Familial hemophagocytic lymphohistiocytosis
  • Familial hemophagocytic lymphohistiocytosis type 4
  • FHL
  • FHLH
  • HLH
  • STX11
  • Syntaxin 11

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America. / Marsh, Rebecca A.; Satake, Noriko; Biroschak, Jennifer; Jacobs, Thedia; Johnson, Judith; Jordan, Michael B.; Bleesing, Jack J.; Filipovich, Alexandra H.; Zhang, Kejian.

In: Pediatric Blood and Cancer, Vol. 55, No. 1, 15.07.2010, p. 134-140.

Research output: Contribution to journalArticle

Marsh, RA, Satake, N, Biroschak, J, Jacobs, T, Johnson, J, Jordan, MB, Bleesing, JJ, Filipovich, AH & Zhang, K 2010, 'STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America', Pediatric Blood and Cancer, vol. 55, no. 1, pp. 134-140. https://doi.org/10.1002/pbc.22499
Marsh, Rebecca A. ; Satake, Noriko ; Biroschak, Jennifer ; Jacobs, Thedia ; Johnson, Judith ; Jordan, Michael B. ; Bleesing, Jack J. ; Filipovich, Alexandra H. ; Zhang, Kejian. / STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America. In: Pediatric Blood and Cancer. 2010 ; Vol. 55, No. 1. pp. 134-140.
@article{b9ccd4bd77fb4199a9c55ace6723f3d7,
title = "STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America",
abstract = "Background. Mutations in STX11 are responsible for Familial Hemophagocytic Lymphohistiocytosis (FHLH) type 4, a rare primary immunodeficiency which has previously been observed only in patients of Kurdish, Turkish, and Lebanese ethnic background. Methods. We reviewed our experience with STX11 mutations among North American patients and studied the impact of patient mutations upon syntaxin 11 expression and NK cell function. Results. Between 2007 and 2008, 243 patients with HLH (lacking disease-causing mutations in PRF1 and UNC13D) were referred for STX11 mutational analysis. We observed 1 novel homozygous nonsense mutation, 73 G> T (E25X), occurring in Hispanic siblings, and 2 novel biallelic heterozygous missense mutations, 106G> C (E36Q) and 616G>A (E206K), occurring in 1 Caucasian patient. The N-terminal nonsense mutation resulted in absence of detectable syntaxin 11 and abrogation of in vitro NK cell degranulation and function, while the biallelic heterozygous missense mutations resulted in detectable mutated syntaxin 11 and preservation of in vitro NK cell degranulation and cytotoxicity. The two sibling patients with the nonsense mutations presented with HLH during infancy, whereas the patient with biallelic heterozygous missense mutations presented at 5 years of age. Conclusion. We conclude that mutations in STX11 are responsible for HLH in approximately 1{\%} of North American patients and can cause variable defects in syntaxin 11 expression and function with resultant impact on clinical phenotype.",
keywords = "Familial hemophagocytic lymphohistiocytosis, Familial hemophagocytic lymphohistiocytosis type 4, FHL, FHLH, HLH, STX11, Syntaxin 11",
author = "Marsh, {Rebecca A.} and Noriko Satake and Jennifer Biroschak and Thedia Jacobs and Judith Johnson and Jordan, {Michael B.} and Bleesing, {Jack J.} and Filipovich, {Alexandra H.} and Kejian Zhang",
year = "2010",
month = "7",
day = "15",
doi = "10.1002/pbc.22499",
language = "English (US)",
volume = "55",
pages = "134--140",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America

AU - Marsh, Rebecca A.

AU - Satake, Noriko

AU - Biroschak, Jennifer

AU - Jacobs, Thedia

AU - Johnson, Judith

AU - Jordan, Michael B.

AU - Bleesing, Jack J.

AU - Filipovich, Alexandra H.

AU - Zhang, Kejian

PY - 2010/7/15

Y1 - 2010/7/15

N2 - Background. Mutations in STX11 are responsible for Familial Hemophagocytic Lymphohistiocytosis (FHLH) type 4, a rare primary immunodeficiency which has previously been observed only in patients of Kurdish, Turkish, and Lebanese ethnic background. Methods. We reviewed our experience with STX11 mutations among North American patients and studied the impact of patient mutations upon syntaxin 11 expression and NK cell function. Results. Between 2007 and 2008, 243 patients with HLH (lacking disease-causing mutations in PRF1 and UNC13D) were referred for STX11 mutational analysis. We observed 1 novel homozygous nonsense mutation, 73 G> T (E25X), occurring in Hispanic siblings, and 2 novel biallelic heterozygous missense mutations, 106G> C (E36Q) and 616G>A (E206K), occurring in 1 Caucasian patient. The N-terminal nonsense mutation resulted in absence of detectable syntaxin 11 and abrogation of in vitro NK cell degranulation and function, while the biallelic heterozygous missense mutations resulted in detectable mutated syntaxin 11 and preservation of in vitro NK cell degranulation and cytotoxicity. The two sibling patients with the nonsense mutations presented with HLH during infancy, whereas the patient with biallelic heterozygous missense mutations presented at 5 years of age. Conclusion. We conclude that mutations in STX11 are responsible for HLH in approximately 1% of North American patients and can cause variable defects in syntaxin 11 expression and function with resultant impact on clinical phenotype.

AB - Background. Mutations in STX11 are responsible for Familial Hemophagocytic Lymphohistiocytosis (FHLH) type 4, a rare primary immunodeficiency which has previously been observed only in patients of Kurdish, Turkish, and Lebanese ethnic background. Methods. We reviewed our experience with STX11 mutations among North American patients and studied the impact of patient mutations upon syntaxin 11 expression and NK cell function. Results. Between 2007 and 2008, 243 patients with HLH (lacking disease-causing mutations in PRF1 and UNC13D) were referred for STX11 mutational analysis. We observed 1 novel homozygous nonsense mutation, 73 G> T (E25X), occurring in Hispanic siblings, and 2 novel biallelic heterozygous missense mutations, 106G> C (E36Q) and 616G>A (E206K), occurring in 1 Caucasian patient. The N-terminal nonsense mutation resulted in absence of detectable syntaxin 11 and abrogation of in vitro NK cell degranulation and function, while the biallelic heterozygous missense mutations resulted in detectable mutated syntaxin 11 and preservation of in vitro NK cell degranulation and cytotoxicity. The two sibling patients with the nonsense mutations presented with HLH during infancy, whereas the patient with biallelic heterozygous missense mutations presented at 5 years of age. Conclusion. We conclude that mutations in STX11 are responsible for HLH in approximately 1% of North American patients and can cause variable defects in syntaxin 11 expression and function with resultant impact on clinical phenotype.

KW - Familial hemophagocytic lymphohistiocytosis

KW - Familial hemophagocytic lymphohistiocytosis type 4

KW - FHL

KW - FHLH

KW - HLH

KW - STX11

KW - Syntaxin 11

UR - http://www.scopus.com/inward/record.url?scp=77953269026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953269026&partnerID=8YFLogxK

U2 - 10.1002/pbc.22499

DO - 10.1002/pbc.22499

M3 - Article

VL - 55

SP - 134

EP - 140

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 1

ER -